top of page

Earlier Lung Cancer Diagnosis in Québec: A New All.Can Canada Initiative

All.Can Canada and its partners are working to identify opportunities to improve the timeliness, efficiency, and equity of lung cancer diagnosis in Québec, bringing together patients, healthcare professionals, researchers, and health system leaders to help shape a better diagnostic pathway.

Why Earlier Lung Cancer Diagnosis Matters
​

Lung cancer remains the leading cause of cancer-related death in Québec and across Canada. Despite advances in detection and treatment, approximately half of lung cancer cases are diagnosed at an advanced stage, when treatment options may be more limited and outcomes are often poorer.

​

Earlier diagnosis offers an important opportunity to improve patient outcomes. However, the journey from the first signs or symptoms of lung cancer to a confirmed diagnosis can be complex, involving multiple healthcare providers, diagnostic tests, referrals, and appointments.​

Doctor and Patient

For patients, delays and gaps in coordination can mean prolonged uncertainty, additional stress, and potentially missed opportunities for earlier intervention. For healthcare systems, inefficient diagnostic pathways can contribute to unnecessary costs, duplication of services, and increased pressure on already stretched resources.

​

Addressing these challenges requires a coordinated, evidence-informed approach that considers both patient experiences and the realities of healthcare delivery.

​

Introducing the Québec Lung Cancer Diagnosis Pathway Initiative

​

All.Can Canada (ACC) has launched a two-year initiative entitled Assessing the Efficiency of Cancer Care in Québec, Canada: Towards an Earlier Lung Cancer Diagnosis Pathway Demonstration Project.​

Screenshot 2026-11-04 at 11.59.05 AM.png

The initiative aims to assess the efficiency of cancer care within Québec's healthcare system, with a particular focus on identifying opportunities to support earlier, more equitable, and more efficient lung cancer diagnosis.

​

A central component of the project is the implementation and practical validation of All.Can's Action Guide for Efficient Cancer Care: An Implementation Toolkit. The Action Guide provides a structured framework for assessing health system preparedness, identifying barriers and opportunities, and supporting collaborative improvements in cancer care.

​

By applying this framework within Québec, the project will help identify where diagnostic delays and inefficiencies occur, explore potential solutions, and build the evidence and partnerships needed to support a future demonstration project.

A Collaborative, Patient-Centred Approach
​

Led by All.Can Canada, the project brings together partners including the Coalition priorité cancer au Québec (Québec Cancer Coalition), Lung Cancer Canada, Association du cancer de l'Est du Québec, Fondation Santé Rouyn-Noranda, Dr. Mylaine Breton of Université de Sherbrooke, and the Best Care Program (One Lung). Save Your Skin Foundation provides secretariat support to All.Can Canada.​

The project is also engaging a broader network of patients, caregivers, primary care providers, specialists, researchers, healthcare administrators, and provincial decision-makers.

Initial regional engagement is focused on three areas of Québec:

  • Abitibi-Témiscamingue

  • Québec City

  • Gaspésie

 

These regions provide opportunities to examine different healthcare delivery contexts, including urban, rural, and remote settings, while exploring opportunities to engage Indigenous communities.

Early conversations with regional stakeholders have generated significant interest in the initiative and highlighted the importance of building on existing work, understanding local challenges, and developing solutions that are both practical and sustainable.

​

Assessing the Efficiency of Cancer Care in Québec, Canada_ Towards an Earlier Lung Cancer
From Research to Action: Three Phases of the Project

​

The initiative is structured around three interconnected phases designed to move from understanding the current state of cancer care toward identifying actionable opportunities for improvement.

Assessing the Efficiency of Cancer Care in Québec, Canada_ Towards an Earlier Lung Cancer
Phase 1: Understanding the Current State
​

The first phase focuses on research, system mapping, and stakeholder engagement. Particular attention is being paid to the role of primary care as a critical entry point into the diagnostic pathway. This includes examining how symptoms such as persistent cough, chronic obstructive pulmonary disease (COPD), and suspicious pulmonary nodules are assessed, and how patients move through referrals, diagnostic imaging, specialist consultations, and confirmation of diagnosis.

​

The next steps include consultations with patients and healthcare professionals, stakeholder interviews, and surveys to gather insights into existing processes, challenges, and opportunities.

​

Phase 2: Analyzing Findings and Identifying Opportunities
​

The second phase will bring together quantitative and qualitative findings from the research and engagement activities.​ The project team will examine the evidence to identify barriers, gaps, strengths, and promising opportunities to improve diagnostic efficiency and equity.

​

This work will also draw on Canadian and international examples of innovative diagnostic pathways, including Alberta's Thoracic Oncology Program, the UK's persistent cough pathway, and the Best Care One Lung initiative.

Findings will inform a comprehensive bilingual report outlining recommendations for improving cancer care efficiency and strengthening lung cancer diagnostic pathways in Québec.

​

Phase 3: Building Consensus and Mobilizing Action
​

The final phase will focus on sharing findings, building consensus, and supporting the next steps toward implementation. A knowledge mobilization event is planned for Québec City in 2027, bringing together patients, healthcare professionals, researchers, policymakers, and other stakeholders to discuss the project's findings and recommendations.

​

The ultimate objective is to build support for a future demonstration project that would test practical improvements to lung cancer diagnostic pathways within Québec's healthcare system. This approach will help ensure that recommendations are grounded in evidence, informed by patient and clinician experiences, and responsive to the needs and capacities of regional healthcare systems.

​

What Does Success Look Like?
​

The initiative aims to achieve three key outcomes:

  1. A clearer understanding of cancer care efficiency in Québec, including the identification of system-level barriers, strengths, and opportunities for improvement.

  2. An evidence-informed assessment of opportunities for earlier lung cancer diagnosis, developed collaboratively with patients, healthcare professionals, and health system stakeholders.

  3. A shared foundation for future action, including consensus and support for a demonstration project to test more timely, equitable, and efficient diagnostic pathways.

 

Beyond Québec, the project's findings may also offer valuable insights for other Canadian jurisdictions working to improve cancer diagnosis and healthcare system efficiency.

 

Stay connected with All.Can Canada for future updates as this important initiative progresses. Sign up for our quarterly newsletter below.

Patient and Nurse

Led by patient groups and those with lived cancer experience, All.Can Canada is a national platform focused on improving cancer diagnosis. It aims to streamline access to timely, accurate, and appropriately delivered diagnoses. All.Can Canada engages government stakeholders, health authorities, healthcare providers, and patient organizations to share key findings and resources with the diagnosis ecosystem to improve patient outcomes.

Led by patient groups and people with lived experiences of cancer, AllCan Canada is a national, multi-stakeholder platform fo

Sign up for our newsletter.

  • Facebook
  • LinledIn
  • YouTube

The head office of Save Your Skin Foundation, the Secretariat of All.Can Canada, is located on the traditional unceded territory of the Syilx Okanagan Nation. The Save Your Skin Foundation and All.Can Canada staff, board, and community are grateful to the Okanagan people, who are the stewards of these beautiful lands.

 

All.Can Canada is an initiative of Save Your Skin Foundation, a not-for-profit organisation registered in Canada. Its work is made possible with financial support from Bristol Myers Squibb, Merck, Novartis, Pfizer, Janssen, AstraZeneca, and Amgen.

​

Charitable Reg. #857756589R

©Copyright 2025 All.Can          Privacy Policy         Terms & Conditions         Land & Community Acknowledgements         Glossary

bottom of page